Vivos therapeutics to participate in upcoming investor conferences

Highlands ranch, colo., march 02, 2022 (globe newswire) -- vivos therapeutics, inc . (“vivos” or the “company'') (nasdaq: vvos), a medical technology company focused on developing and commercializing a suite of innovative diagnostic and treatment modalities for patients with dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (osa) and snoring, today announced that kirk huntsman, chief executive officer, will participate in the following upcoming conferences.
VVOS Ratings Summary
VVOS Quant Ranking